eplerenone and Macular-Degeneration

eplerenone has been researched along with Macular-Degeneration* in 1 studies

Other Studies

1 other study(ies) available for eplerenone and Macular-Degeneration

ArticleYear
One-year outcome of cystoid macular degeneration in central serous chorioretinopathy.
    European journal of ophthalmology, 2022, Volume: 32, Issue:4

    To study structural and functional outcomes of cystoid macular degeneration (CMD) in chronic central serous chorioretinopathy (CSCR).. This retrospective study included 26 eyes having chronic CSCR with CMD who underwent either observation, photodynamic therapy (PDT), micropulse laser, or eplerenone therapy. Various optical coherence tomography parameters were analyzed at baseline and 1 year.. Number of eyes that maintained or gained vision after treatment was 63.1%, compared to a loss of 2.1 ± 1.1 lines in observation group. Sub-foveal large choroidal vessel responded to PDT (. Treatment of eyes with CMD prevents further deterioration of vision. Round configuration of intra-retinal cystoid space has a better anatomical outcome.

    Topics: Central Serous Chorioretinopathy; Chronic Disease; Eplerenone; Fluorescein Angiography; Humans; Macular Degeneration; Photochemotherapy; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity

2022